A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy

Clinical trial NCT00144495 · COMPLETED

Trial details

NCT number: NCT00144495
Sponsor: Chugai Pharmaceutical
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chemotherapy Induced Anemia

Start date: 2004-02-01
Primary completion: 2004-11-01
Enrollment: 104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.